Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment. - MarketWatch
1. FDA approved Vertex's non-opioid pain treatment, Journavx. 2. Journavx is the first new pain treatment class in 20 years. 3. Price per 50mg pill is $15.50, aligning with analyst expectations. 4. The drug showed significant pain reduction in clinical trials. 5. Vertex evaluating Journavx's use for peripheral neuropathic pain.